[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$1578bAbbVie reports strong Q3 earnings with $15.78B revenue, beating estimates and raising FY EPS guidance. However, concerns linger over price volatility and a recent dip in social media engagement for $1578b.
$1578b is a cryptocurrency experiencing mixed market sentiment.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXXX +4,352%
1 Month: XXXXXX +210%
6 Months: XXXXXXX +1,418%
1 Year: XXXXXXX +236%
1-Year High: XXXXXX on 2025-10-31
1-Year Low: X on 2024-12-26
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: X
1 Week: X -XX%
1 Month: X -XX%
6 Months: XX +250%
1 Year: XX +126%
1-Year High: XX on 2025-11-02
1-Year Low: X on 2024-11-03
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $1578b in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: X
1 Week: XX +767%
1 Month: XX +329%
6 Months: XX +489%
1 Year: XX +228%
1-Year High: XX on 2025-11-02
1-Year Low: X on 2024-11-03
The most influential creators that mention $1578b in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AponiaAnalytics | X | XXXXX | X | X |
| @MarketNews_Feed | X | XXXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Month: XXX% +50%
1 Year: XXX% +50%
1-Year High: XXX% on 2025-05-14
1-Year Low: XX% on 2025-09-04
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XX | X% | ||
| Total | XX | X% | XXX | XX% | X | NaN% |
Top assets mentioned In the posts about $1578b in the last XX hours
AbbVie Inc (ABBV) IBM (IBM) Comcast Corporation (CMCSA) Boeing Co (BA) Coca-Cola Co (KO) Advanced Micro Devices (AMD) Pfizer, Inc. (PFE) Microsoft Corp. (MSFT) ServiceNow Inc (NOW) Cognizant Technology Solutions Corp (CTSH)
Top topics mentioned In the posts about $1578b in the last XX hours
stocks healthcare, $abbv, $471b, $1559b, $993m, $458b, $218b, eps, $114b, $1558b, abbv, $173shr, $216b, $706m, $7224m, investment, $789b, stocks technology, $173share, stocks, $186m, ibm, $393share, $341b, $312b, stocks communication services, $cmcsa, $2327b, stocks defense, stocks industrials, $ba, stocks consumer defensive, $ko, advanced micro devices, $pfe, microsoft, $44m, ai, $104b, $868b, $8529b, $47b, $200m, $schd, ceos, $0981hk, china, ukraine, eu, $168b, $985m, $934m, $284b, $1557b, $103m, servicenow, $139share, $542b, $ctsh, cognizant technology solutions corp, avnt, $600m, money, coins perpetuals, coins derivatives, coins base ecosystem, coins made in usa, coins defi, $avnt, $87m, $62m, $185b, meta
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"ABBVIE Q3 2025: ADJUSTED EPS $XXXX ON $15.78B REVENUE; RINVOQ AND SKYRIZI DRIVE GROWTH HUMIRA SALES FALL ON LOSS OF EXCLUSIVITY; FY2025 ADJUSTED EPS GUIDANCE RAISED TO $10.61-$10.65"
X Link @MultibaggAIUS 2025-10-31T21:37Z XX followers, XX engagements
"#Earnings ABBV Q3: Rev. $15.78B +9% YoY; EPS $XXXX (vs $XXXX est) XOM Q3: Rev. $85.29B (vs $86.8B est); EPS $XXXX (vs $XXXX est) LYB Q3: Rev. $10.4B -X% YoY; EPS $XXXX (vs $XXXX est) Next: Pfizer AMD Nov X Procter & Gamble Coca-Cola Nov 3-4 IBM RTX Nov 4"
X Link @CXL_LAB 2025-10-31T19:16Z 2473 followers, 1856 engagements
"$ABBV 🦉 AbbVie Reports Third-Quarter 2025 Financial Results AbbVie Q3 revenue rose XXX% to $15.78B led by Skyrizi ($4.7B) and Rinvoq ($2.18B). Adjusted EPS fell XX% to $1.86; dividend up XXX% for 2026. #newsrelease"
X Link @AponiaAnalytics 2025-10-31T16:09Z 5158 followers, XX engagements
"$ABBV AbbVie just dropped monstrous Q3 results 💥 💰Revenue: $15.78B (+9.1% YoY) 📈EPS: $XXXX (beat by $0.08) Rinvoq +35% Skyrizi +47% both now offset Humiras decline. ❗AbbVie isnt just surviving post-Humira. Its reinventing itself --expanding into immuno-oncology with Elahere Epkinly and two new acquisitions: Capstan & Nimble. Skyrizi + Rinvoq = the new cash cows. My full breakdown: #Pharma #Investing #Biotech"
X Link @ALLKAResearch 2025-10-31T15:21Z XXX followers, XXX engagements